Topic

Peter O'Donnell is a freelance journalist who specializes in European health affairs and is based in Brussels, Belgium.

Articles

Increased public engagement leads recent change in EMA profile.

EMA: A Change in Character as Well as Powers?

Higher costs headline list of new challenges faced by CROs and sponsors.

Consequences of Brexit for Clinical Trials in Europe

Cancer still a primary focus of EMA in light of COVID and vaccine development.

EMA’s Cooke Reviews European Cancer Prospects

EMA Publishes Human Medicines: Highlights of 2020

Europe's research ministers are will meet to attempt to reach agreement on European Union research plans for the next seven years, including a cluster devoted to a broad range of health goals that range from general objectives to subjects of more specific interest to the community.

Europe Edges Towards a Health Research Plan

The European Commission has concluded exploratory talks, with Moderna, over the purchase of a fifth potential vaccine against COVID-19.

EU Makes More Vaccine Deals as Questions Mount Over Terms

EU Scoops Up Further Vaccine Deals as Questions Mount Over Terms

Europe is aiming to improve its medium-term planning for citizens' health with an agenda that aims to "enable and leverage research and innovation in regulatory science."

EU Planning to Respond to Drug Innovation with Smarter Regulation by 2025

EMA has launched a "communication perception survey" looking for honest views from among the widest audience on how well it is doing. 

EMA Looks to Its Image

The search for a coronavirus vaccine is just one of many questions unanswered on European health policy.